Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Virtual reality headsets tested to soothe ICU Patients' discomfort

NCT ID NCT06830369

Symptom relief Sponsor: Centre Hospitalier Universitaire, Amiens Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether using a virtual reality headset (HypnoVR) can reduce discomfort in patients recovering in the intensive care unit after major heart, chest, or abdominal surgery. 194 adults will be randomly assigned to either standard care or twice-daily VR sessions for 10-20 minutes. The main goal is to measure comfort using a validated questionnaire at ICU discharge.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
HypnoVR virtual reality device
What this could lead to
If it works, this could offer a drug-free way to ease discomfort and anxiety for patients in intensive care after major surgery.
What could go wrong
This is a small, early-stage trial at one hospital. The effect may be small or not apply to other ICUs. VR headsets may not be comfortable for all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 194 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2025

Expected to finish

Oct 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients over 18 years old * scheduled for a major surgery (cardiothoracic surgery or a major abdominal surgery) * Written informed consent from patient. * Admitted in a surgical ICU for a postoperative care for at least 48 hours. * Absence of delirium at inclusion (RASS and CAM-ICU scale) Exclusion Criteria: * Missing informed consent * Patient strictly under 18 years old * Inclusion in other study within the last 30 days * Pregnancy * Emergency hospitalization * Progressive sepsis * Patient transferred from another intensive care unit * Short-term life-threatening condition * Active psychiatric illness requiring antidepressant, antipsychotic or anxiolytic treatment * Mechanical ventilation \> 48 hours * Patient known to have cognitive disorders. * Unbalanced epilepsy * Visual problems (absence of binocular vision, blindness) and/or auditory problems (deafness) preventing the use of virtual reality * Pregnant or breast-feeding women * Patients under guardianship or deprived of their liberty * Patients not registered with the national social security system

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Delirium are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

delirium

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Delirium Discomfort Immersive virtual reality Intensive care unit IPREA

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • CHRU Amiens

    RECRUITING

    Amiens, 80054, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.